| Literature DB >> 27231539 |
Thyra E de Jongh1, Ipek Gurol-Urganci2, Elizabeth Allen3, Nina Jiayue Zhu3, Rifat Atun3.
Abstract
BACKGROUND: Antenatal care (ANC) presents a potentially valuable platform for integrated delivery of additional health services for pregnant women-services that are vital to reduce the persistently high rates of maternal and neonatal mortality in low- and middle-income countries (LMICs). However, there is limited evidence on the impact of integrating health services with ANC to guide policy. This review assesses the impact of integration of postnatal and other health services with ANC on health services uptake and utilisation, health outcomes and user experience of care in LMICs.Entities:
Mesh:
Year: 2016 PMID: 27231539 PMCID: PMC4871065 DOI: 10.7189/jogh.06.010403
Source DB: PubMed Journal: J Glob Health ISSN: 2047-2978 Impact factor: 4.413
Figure 1Flowchart showing process of screening and selection of studies for inclusion.
Summary of included studies
| Geelhoed 2013 [ | ART, PMTCT | Mozambique (376) | Controlled before–and–after study | MCH nurses provided all recommended health interventions applicable to both mother and child, including follow–up of HIV–exposed infants and early infant diagnosis of HIV, during the antenatal, postnatal, family planning, growth monitoring, high–risk child and vaccination consultations. | In the health care facilities of the control group, the same services were provided separately, one type of services after another, as is routine in the Mozambican public health care system. | Follow–up of HIV–exposed infants (registration, follow–up visits, serological testing); MCH attendance; Acceptability of integrated services to health care providers. |
| van’t Hoog 2005 [ | PMTCT | Kenya (8231) | Historically controlled trial | HIV pre– and post–test counselling from an ANC nurse–counsellor; HIV testing at an on–site facility. The same counsellor also provided routine ANC preventive interventions like tetanus toxoid and sulfadoxine–pyrimethamine. | Opt–in HIV counselling was provided in a separate location within the hospital complex. HIV testing was conducted in an off–site laboratory. | Uptake of HIV counselling, testing and uptake of NVP. |
| Kasenga 2009 [ | PMTCT | Malawi (1259) | Historically controlled trial | HIV testing and counselling services, and later on also management of sexually transmitted infections, were integrated within ANC. | Voluntary counselling and testing services were offered through a separate VCT unit at the outpatient department, through an opt–in approach. | Uptake of HIV testing |
| Killam 2010 [ | ART | Zambia (31 536) | Stepped–wedge cluster non–randomised trial | Eligible women received ART in ANC until 6 weeks postpartum and then were referred to the general ART clinic. | Women found to be seropositive through ANC testing and eligible for ART were referred to the ART clinic, located on the same premises as ANC, but physically separated and separately staffed. | Proportion of treatment eligible pregnant women enrolling into HIV care within 60 d of HIV diagnosis; Proportion of women initiating ART during pregnancy. |
| Van der Merwe [ | ART | South Africa (164) | Historically controlled trial | HIV testing, ART adherence counselling and treatment preparation took place within ANC. Thereafter, women were referred to hospital for initiation and follow–up of ARV treatment, which, whenever possible, was provided by the same staff members who began treatment preparation. | Pregnant women with indications for ARV treatment were referred to a hospital located approximately 1 km away, for preparation and initiation of treatment and long–term follow–up. These women were “fast–tracked” into treatment. | Pregnancy outcomes; Time–to–treatment initiation; Gestational age at ARV treatment initiation; Time from ARV treatment initiation to childbirth; Time between HIV diagnosis and receiving CD4 cell count results. |
| Ong’ech 2012 [ | PMTCT | Kenya (363) | Prospective cohort study | Early infant HIV testing and prophylaxis were provided in the Maternal and Child Health clinic. | Infants were escorted to the Comprehensive Care Clinic, within the same health facility, for all HIV–related services. | Rates of attendance at each study visit (9 and 12 mo) and receipt of services for: infant HIV testing and prophylaxis at 6–8 weeks, receipt of immunizations at 14 weeks, continuation of prophylaxis at 6 mo, measles immunization at 9 mo, and HIV antibody testing at 12 mo. |
| Pfeiffer 2010 [ | ART | Mozambique (unknown) | Retrospective cohort study | At integrated sites, HIV–positive women were referred to the ART clinic from ANC services within the same health unit. | At vertical sites, HIV–positive women were referred to the ART clinic from ANC services at other health units. | Loss to follow–up from referrals of HIV–positive women from PMTCT services to ART services. |
| Stitson 2010 [ | ART | South Africa (14 987) | Retrospective cohort study | Site 1: ART initiated within the antenatal clinic when obstetricians with an HIV specialisation were on site. Site 2: women were referred by letter to a separate ART service located within 100 m of the maternity unit on the same premises. | Eligible women at the ANC clinic were referred to another site for HIV counselling and opt–in testing. ART was delivered at a separate primary health care facility approximately three kilometres from the antenatal service, using a referral letter. | Proportion of women who received more than 8 weeks of HAART; initiation of HAART in pregnancy. |
| Stinson 2013 [ | ART | South Africa (14 617) | Retrospective cohort study. | See Stinson 2010. | See Stinson 2010. | Proportion of women who initiated ART before delivery; Time to treatment initiation. |
| Turan 2012 [ | ART, PMTCT | Kenya (1123) | Cluster–RCT | At the fully integrated sites, HIV positive women were provided all ANC, PMTCT, and HIV services in the ANC clinic, including HAART for women who were eligible. | In the control (non–integrated) clinics ANC and basic PMTCT services were provided in one visit, with referral to a separate clinic in the same health facility for HIV care and treatment (including HAART if indicated, opportunistic infection prophylaxis, education, and adherence counselling). | Baseline data only (aims to report HIV–free infant survival at 6 mo; rates of maternal enrolment in HIV care and treatment; infant HIV testing uptake at 3 mo). |
| Vo 2012 [ | ART | Kenya (326) | Nested cross–sectional study | See Turan 2012 | See Turan 2012 | Satisfaction; Preferred service model; average wait times. |
| Winestone 2012 [ | ART, PMTCT | Kenya (36 providers) | Qualitative study | See Turan 2012 | See Turan 2012 | Provider perceptions of quality of care. |
| Munkhuu 2009 [ | Congenital syphilis testing | Mongolia (7700) | Cluster–RCT | The one–stop service included: (i) on–site screening for syphilis using rapid syphilis tests at the first antenatal visit and at the third trimester of gestation; (ii) immediate on–site treatment for seropositive women and their sexual partners; and (iii) pre– and post–test counselling. | After being admitted to the antenatal clinic, a pregnant woman could visit any District General Hospital or the National Center of Infectious Diseases for free initial and confirmatory syphilis testing. Women testing positive would be sent to a venereologist for appropriate case management and follow–up control, including contact tracing and counselling. | Uptake of syphilis testing at the first visit and third trimester; Receipt of adequate treatment (ie, completion of 3 doses of treatment before delivery); Treatment rates for sexual partners. |
| Bronzan 2007 [ | Congenital syphilis testing | South Africa (1250) | Non–randomised controlled trial | On–site antenatal syphilis screening | Off–site syphilis screening | Percentage of eligible women who received 1, 2, or 3 appropriately timed weekly doses of penicillin; Acceptability of onsite testing to nurse clinicians. |
| Rahman 2011 [ | Various | Bangladesh (20 766) | Controlled before–and–after study | Set of maternal and neonatal interventions, following the continuum of care approach from pregnancy to delivery to the postnatal period, with improved links between community– and facility–based service delivery modes. | In the control areas, women receive pregnancy, delivery, and post–natal care from various government health facilities. | Perinatal mortality; Rates of facility deliveries and caesarean section. |
ANC – Antenatal care; ART – Antiretroviral therapy; ARV – Antiretroviral; HAART – Highly active antiretroviral therapy; PMTCT – Prevention of mother–to–child transmission
Risk of bias assessment (EPOC criteria) of included RCTs, SWTs, CBAs and NRCTs
| Munkhuu 2009 [ | Turan 2012 [ | Killam 2010 [ | Geelhoed 2013 [ | Rahman 2011 [ | Bronzan 2007 [ | |
|---|---|---|---|---|---|---|
| Sequence generation | U | L | H | L | N/A | N/A |
| Allocation concealment | U | U | H | U | N/A | N/A |
| Blinding | U | L | L | U | U | U |
| Complete outcome data | L | L | L | N/A | N/A | N/A |
| No selective outcome reporting | U | N/A | U | U | U | U |
| Group comparability | L | L | L | U | L | U |
| Protection against contamination | U | L | U | U | U | H |
| Free from other sources of bias | L | U | L | U | L | H |
cRCT – cluster–randomized controlled trial, CBA – controlled before–and–after trial, NRCT – non–randomised controlled trial, SWT – stepped wedge trial, H – High risk, L – Low risk, U – Unclear, N/A – Not applicable
Risk of bias assessment for included NRS based on the Newcastle–Ottawa scale
| Ong’ech 2012 [ | Pfeiffer 2010 [ | Stinson 2010, 2013 [ | Kasenga 2009 [ | Van der Merwe 2006 [ | van’t Hoog 2005 [ | |
|---|---|---|---|---|---|---|
| Representativeness | ★ | – | ★ | ★ | ★ | ★ |
| Selection of control | ★ | ★ | – | ★ | ★ | ★ |
| Exposure | ★ | – | ★ | ★ | ★ | – |
| Baseline | ★ | – | ★ | ★ | ★ | ★ |
| ★ | – | ★ | – | ★ | – | |
| Assessment methods | ★ | – | ★ | ★ | ★ | ★ |
| Follow–up | ★ | ★ | ★ | ★ | ★ | ★ |
| Loss–to–follow–up* | – | – | – | – | – | – |
*As all included NRS used uptake and utilisation of services during pregnancy as their primary outcome, no follow–up beyond the point of recorded uptake of services was reported. We therefore did not award any stars in this category.
Figure 2Uptake and utilisation of HIV services (integrated care vs controls). (1) HIV testing within ANC; (2) Infant DBS–PCR testing at 6–8 weeks; (3) Pre–test counselling; (4) Post–test counselling; (5) HIV testing within ANC; (6) Enrollment to HIV–care within 60 days of diagnosis; (7) Women registered for HIV care <30 days post–test (missing data, contact); (8) Nevirapine at delivery; (9) ART initiation during pregnancy; (10) Infant CTX initiation at 6–8 weeks (100% success in intervention group); (11) ART; (12) HAART; (13) Nevirapine uptake; (14) Measles immunization at 9 months; (15) Oral polio vaccine at 14 weeks nths; (16) Complete vaccination by 12 months; (17) DPT vaccine at 14 weeks; (18) 90–day retention among patients initiating ART; (19) 9–month postnatal visit; (20) 6–month postnatal visit; (21) Continuation of CTX prophylaxis at 6 months; (22) 14–week postnatal visit, (23) 12–month postnatal visit; (24) HIV antibody test at 12 months.
Timeliness of treatment initiation
| Measure | Integrated | Control | ||
|---|---|---|---|---|
| Killam 2010 [ | Mean (SD) | 10 (N/A) | 11 (N/A) | NS |
| van der Merwe 2006 [ | Median (IQR) | 7 (3.9–11.2) | 5 (2–10) | NS |
| Killam 2010 [ | Mean (SD) | 22 (N/A) | 22 (N/A) | NS |
| van der Merwe 2006 [ | Median (IQR) | 32 (28–35) | 33.5 (31–36) | 0.042 |
| Stinson 2013 [ | Median (IQR) | 31 (28–34) | 30 (27–34) | NS |
| van der Merwe 2006 [ | Median (IQR) | 29 (11.5–45) | 50 (22–92) | 0.047 |
| Stinson 2013 [ | Median (IQR) | 36 (N/A) | 59 (N/A) | <0.001 |
| van der Merwe 2006 [ | Median (IQR) | 37 (22–63) | 56 (30–103) | 0.041 |
SD – standard deviation, IQR – interquartile range, N/A – not applicable, NS – not significant
Figure 3Uptake and utilization of syphilis screening services (integrated care vs controls). (1) Coverage at 1st antenatal visit; (2) Coverage at 3rd trimester; (3) Cases at 1st antenatal visit; (4) Cases at 3rd trimester; (5) At least one appropriately timed penicillin dose/week; (6) One appropriately timed penicillin dose/week; (7) Two appropriately timed penicillin doses/week; (8) Three appropriately timed penicillin doses/week; (9) Adequate treatment; (10) Partner treatment.
Figure 4Health outcomes (odds of adverse health outcomes in integrated care vs controls). (1) Perinatal mortality, adjusted; (2) Number of HIV infections among infants born to HIV+ mothers; (3) Number of congenital syphilis cases.